Humer Kristian insider trades
Humer Kristian has filed 12 Form 4s with the SEC that we hold, for Faeth Therapeutics, Inc. (SNSE) (Director), Viridian Therapeutics, Inc.\DE (VRDN) (CFO and CBO), Foghorn Therapeutics Inc. (FHTX) (Chief Financial Officer) and 4D Molecular Therapeutics, Inc. (FDMT) (Chief Financial Officer). None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2021-07-27 and the latest 2025-12-11.
Faeth Therapeutics, Inc. (SNSE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Viridian Therapeutics, Inc.\DE (VRDN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Foghorn Therapeutics Inc. (FHTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
4D Molecular Therapeutics, Inc. (FDMT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1872280) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms